The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents.


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
11 Nov 2022
Historique:
received: 23 05 2022
entrez: 21 11 2022
pubmed: 22 11 2022
medline: 22 11 2022
Statut: epublish

Résumé

The multifactorial nature of Alzheimer's disease necessitates the development of agents able to interfere with different relevant targets. A series of 22 tailored chromanones was conceptualized, synthesized, and subjected to biological evaluation. We identified one representative bearing a linker-connected azepane moiety (compound

Identifiants

pubmed: 36407962
doi: 10.1021/acsptsci.2c00097
pmc: PMC9667544
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1097-1108

Informations de copyright

© 2022 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): M.A.M.G. and C.D.B. are former employees of Eli Lilly & Company.

Références

RSC Med Chem. 2020 Jan 7;11(2):225-233
pubmed: 33479629
J Phys Chem B. 2009 Aug 13;113(32):11216-21
pubmed: 19618949
J Med Chem. 2021 Jun 24;64(12):7926-7962
pubmed: 34076441
Eur J Med Chem. 2008 Apr;43(4):707-13
pubmed: 17618710
ACS Chem Neurosci. 2022 Jan 5;13(1):1-15
pubmed: 34908391
Med Res Rev. 2013 Jan;33(1):139-89
pubmed: 21793014
Bioorg Chem. 2019 Aug;89:103027
pubmed: 31176237
Alzheimers Dement. 2021 Aug;17(8):1365-1382
pubmed: 33559354
Nat Struct Mol Biol. 2018 Oct;25(10):981-987
pubmed: 30291362
J Med Chem. 2017 Aug 24;60(16):7206-7212
pubmed: 28753307
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
J Med Chem. 2006 Oct 19;49(21):6264-72
pubmed: 17034132
Bioorg Med Chem. 2014 Mar 15;22(6):1916-28
pubmed: 24560738
J Neural Transm (Vienna). 2007;114(6):707-12
pubmed: 17401535
J Neurochem. 2017 Feb;140(4):561-575
pubmed: 27926996
Free Radic Biol Med. 2019 Mar;133:221-233
pubmed: 30266679
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126880
pubmed: 31864798
J Med Chem. 2018 Aug 09;61(15):6937-6943
pubmed: 29969030
Future Med Chem. 2018 Jan;10(2):231-256
pubmed: 29185346
ACS Omega. 2019 Dec 11;4(26):22161-22168
pubmed: 31891098
Nat Rev Dis Primers. 2021 May 13;7(1):33
pubmed: 33986301
Future Med Chem. 2017 May;9(8):811-832
pubmed: 28504893
J Med Chem. 2013 Dec 27;56(24):9809-19
pubmed: 23964901
ACS Chem Neurosci. 2019 Feb 20;10(2):852-862
pubmed: 30521323
Eur J Med Chem. 2017 Sep 29;138:964-978
pubmed: 28756263
Biomolecules. 2022 Feb 25;12(3):
pubmed: 35327555
J Enzyme Inhib Med Chem. 2016;31(3):389-97
pubmed: 25798687
J Med Chem. 2019 Jan 24;62(2):420-444
pubmed: 30035545
Arch Toxicol. 2002 Sep;76(9):523-9
pubmed: 12242610
Mol Med Rep. 2014 May;9(5):1533-41
pubmed: 24626484
FEBS J. 2008 Aug;275(15):3850-8
pubmed: 18573102
RSC Med Chem. 2021 May 20;12(6):1000-1004
pubmed: 34223165
ACS Chem Neurosci. 2018 Mar 21;9(3):401-403
pubmed: 29465220
J Med Chem. 2019 Apr 25;62(8):4204-4217
pubmed: 30939014
J Med Chem. 2018 Jan 11;61(1):119-139
pubmed: 29227101
Front Aging Neurosci. 2022 Feb 09;14:837649
pubmed: 35222001
J Med Chem. 2015 Jul 23;58(14):5561-78
pubmed: 26107513
Mol Neurobiol. 2021 Nov;58(11):5649-5666
pubmed: 34383254
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
Chem Rev. 2009 Jun;109(6):2551-651
pubmed: 19382806
ACS Med Chem Lett. 2020 Jul 27;11(8):1555-1561
pubmed: 32832023
Bioengineered. 2022 Jan;13(1):1921-1930
pubmed: 35001806
Br J Pharmacol. 2015 May;172(10):2519-31
pubmed: 25573298
Front Aging Neurosci. 2019 Jul 11;11:175
pubmed: 31354471
ChemMedChem. 2022 Apr 5;17(7):e202100735
pubmed: 35077612
Mol Med Rep. 2019 Aug;20(2):1479-1487
pubmed: 31257471
Curr Protoc Pharmacol. 2015 Dec 08;71:1.34.1-1.34.21
pubmed: 26646191
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12765-12769
pubmed: 28861918
Eur J Med Chem. 2015 Mar 6;92:575-82
pubmed: 25602932
ACS Med Chem Lett. 2022 Feb 18;13(3):499-506
pubmed: 35300078
Future Med Chem. 2018 Dec 6;:
pubmed: 30518272
Drug Discov Today. 2013 Sep;18(17-18):795-802
pubmed: 23523957

Auteurs

Tim Keuler (T)

Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.

Carina Lemke (C)

Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.

Paul W Elsinghorst (PW)

Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
Central Institute of the Bundeswehr Medical Service Munich, Ingolstädter Landstraße 102, 85748 Garching Germany.

Isabel Iriepa (I)

Universidad de Alcalá, Departamento de Química Orgánica y Química Inorgánica, Ctra. Madrid-Barcelona, 28871 Alcalá de Henares, Madrid España.

Mourad Chioua (M)

Laboratory of Medicinal Chemistry, IQOG, CSIC, C/Juan de la Cierva 3, 28006 Madrid, Spain.

María Angeles Martínez-Grau (MA)

Lilly Research Laboratories, Eli Lilly & Company, Avda. de la Industria 30, 28108 Alcobendas, Madrid Spain.

Christopher D Beadle (CD)

Lilly Research Centre, Eli Lilly & Company, Erl Wood Manor, Windlesham, Surrey GU20 6PH, United Kingdom.

Tatiana Vetman (T)

Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285, United States.

Francisco López-Muñoz (F)

Faculty of Health, Camilo José Cela University of Madrid (UCJC), Neuropsychopharmacology Unit, "Hospital 12 de Octubre" Research Institute, 28692 Madrid, Spain.

Timo Wille (T)

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstraße 11, 80937 München, Germany.

Ulrike Bartz (U)

Department of Natural Sciences, University of Applied Sciences Bonn-Rhein-Sieg, von-Liebig-Straße 20, 53359 Rheinbach, Germany.

Winnie Deuther-Conrad (W)

Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Neuroradiopharmaceuticals, 04318 Leipzig, Germany.

José Marco-Contelles (J)

Laboratory of Medicinal Chemistry, IQOG, CSIC, C/Juan de la Cierva 3, 28006 Madrid, Spain.

Michael Gütschow (M)

Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.

Classifications MeSH